Adicet Bio Inc

NASDAQ:ACET  
9.82
-0.53 (-5.12%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)183.01M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$4.19 Million
Adjusted EPS-$0.43
See more estimates
10-Day MA$9.86
50-Day MA$8.74
200-Day MA$10.53
See more pivots

Adicet Bio Inc Stock, NASDAQ:ACET

500 Boylston Street, 13th floor, Boston, Massachusetts 02116
United States of America
Phone: +1.857.315.5528
Number of Employees: 81

Description

Adicet Bio, Inc. is a biotechnology company, which engages in the design and development of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.